Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Sopharma AD - Filing #6022421

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Disclosure of effect of changes in foreign exchange rates [text block]		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	—	727 099 BGN	—	—	—	—	—	—	681 487 BGN	—	—	—	—	—	—	—
Current assets	—	787 063 BGN	—	—	—	—	—	—	572 491 BGN	—	—	—	—	—	—	—
Non-current liabilities	—	151 346 BGN	—	—	—	—	—	—	129 998 BGN	—	—	—	—	—	—	—
Current liabilities	—	609 190 BGN	—	—	—	—	—	—	407 346 BGN	—	—	—	—	—	—	—
Revenue	1 875 304 BGN	—	—	—	—	—	—	—	—	—	—	1 663 016 BGN	—	—	—	—
Profit (loss)	99 874 BGN	—	3 897 BGN	95 977 BGN	95 977 BGN	—	—	—	—	71 121 BGN	—	76 333 BGN	—	71 121 BGN	5 212 BGN	—
Other comprehensive income	3 915 BGN	—	84,000 BGN	1 388 BGN	3 999 BGN	1 766 BGN	30,000 BGN	3 591 BGN	—	6 011 BGN	892,000 BGN	5 868 BGN	1 047 BGN	1 355 BGN	143,000 BGN	5 427 BGN
Comprehensive income	103 789 BGN	—	3 813 BGN	94 589 BGN	99 976 BGN	1 766 BGN	30,000 BGN	3 591 BGN	—	65 110 BGN	892,000 BGN	70 465 BGN	1 047 BGN	72 476 BGN	5 355 BGN	5 427 BGN